AcelRx Pharma (NASDAQ: ACRX) reported Q1 EPS of ($0.24), $0.04 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $1.62 million.

For earnings history and earnings-related data on AcelRx Pharma (ACRX) click here.